HomeINMB • NASDAQ
add
INmune Bio Inc
Previous close
$10.62
Day range
$10.04 - $11.15
Year range
$6.50 - $14.74
Market cap
203.52M USD
Avg Volume
121.55K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 28.00K | -71.13% |
Operating expense | 8.41M | 46.49% |
Net income | -8.41M | -44.15% |
Net profit margin | -30.03K | -399.36% |
Earnings per share | -0.47 | -46.87% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.85M | -31.26% |
Total assets | 57.00M | -30.31% |
Total liabilities | 18.86M | -13.04% |
Total equity | 38.14M | — |
Shares outstanding | 18.03M | — |
Price to book | 5.11 | — |
Return on assets | -35.00% | — |
Return on capital | -39.44% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -8.41M | -44.15% |
Cash from operations | -3.40M | 40.28% |
Cash from investing | — | — |
Cash from financing | -2.50M | — |
Net change in cash | -5.96M | -13.58% |
Free cash flow | 274.25K | 107.36% |
About
Founded
2015
Headquarters
Website
Employees
14